US Stock MarketDetailed Quotes
OMER Omeros
- 11.790
- +0.880+8.07%
Close Nov 25 16:00 ET
- 11.790
- 0.0000.00%
Post 16:00 ET
683.23MMarket Cap-5126P/E (TTM)
11.820High10.360Low2.09MVolume10.990Open10.910Pre Close22.96MTurnover3.77%Turnover RatioLossP/E (Static)57.95MShares11.82052wk High-4.43P/B652.86MFloat Cap2.22052wk Low--Dividend TTM55.37MShs Float30.230Historical High--Div YieldTTM13.38%Amplitude0.920Historical Low10.997Avg Price1Lot Size
About Omeros Company
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Company Profile
SymbolOMER
Company NameOmeros
Listing DateOct 8, 2009
Issue Price10.00
Founded1994
CEODr. Gregory A. Demopulos,M.D.
MarketNASDAQ
Employees198
Fiscal Year Ends12-31
AddressThe Omeros Building,201 Elliott Avenue West
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98119
Phone1-206-676-5000
Websitehttp://www.omeros.com
Company Executives
- Name
- Position
- Salary
- Dr. Gregory A. Demopulos,M.D.
- Chairman of the Board, President and Chief Executive Officer
- 7.69M
- Nadia Dac
- Vice President and Chief Commercial Officer
- --
- David J. Borges
- Vice President, Finance, Chief Accounting Officer, Principal Financial Officer and Treasurer
- --
- Dr. George A. Gaitanaris, M.D.,PhD
- Vice President, Science and Chief Scientific Officer
- --
- Dr. Catherine A. Melfi, PhD
- Vice President, Regulatory Affairs and Quality Systems and Chief Regulatory Officer
- --
- Dr. Andreas Grauer, M.D.
- Vice President and Chief Medical Officer
- --
- Dr. J. Whitaker, J.D.,M.D.
- Vice President, Clinical Development
- --
- Peter W. Williams
- Vice President, Human Resources
- --
- Peter B. Cancelmo
- Vice President, General Counsel and Corporate Secretary
- 852.63K
- Dr. Mariana N. Dimitrova
- Vice President, Chemistry, Manufacturing and Controls
- --
- Dr. Peter A. Demopulos,M.D.
- Director
- 122.60K
- Diana T. Perkinson
- Director
- 174.66K
- Dr. Thomas F. Bumol, PhD
- Independent Director
- 127.60K
- Dr. Rajiv Shah, M.D.
- Independent Director
- 140.10K
- Dr. Leroy E. Hood,M.D.,Ph.
- Independent Director
- 135.10K
- Arnold C. Hanish
- Independent Director
- 137.60K
- Thomas J. Cable
- Lead Independent Director
- 177.60K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
